InvestorsHub Logo
Post# of 252337
Next 10
Followers 8
Posts 511
Boards Moderated 0
Alias Born 08/03/2005

Re: DewDiligence post# 241169

Wednesday, 01/12/2022 5:09:47 PM

Wednesday, January 12, 2022 5:09:47 PM

Post# of 252337
Re: ABBV

They are great at execution in immunology, but I think that can only take you so far given the headwinds and intensifying competition. This is one of those "two turkeys don't make an eagle" situations. Even in the best case (which we are definitely no longer in, as far as the JAKs are concerned), replacing HUMIRA revenue across all of its indications (while competing with it) would be a very tall order.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.